Phyllis D. Kind

976 total citations
33 papers, 756 citations indexed

About

Phyllis D. Kind is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Phyllis D. Kind has authored 33 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Phyllis D. Kind's work include Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Phyllis D. Kind is often cited by papers focused on Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Phyllis D. Kind collaborates with scholars based in United States, Germany and Egypt. Phyllis D. Kind's co-authors include Arthur G. Johnson, Priscilla A. Campbell, John J. Farrar, P L Simon, C R Manclark, Bruce D. Meade, John R. Ortaldo, G D Bonnard, Ernst Gleichmann and John Cohen and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Infection and Immunity.

In The Last Decade

Phyllis D. Kind

33 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phyllis D. Kind United States 16 413 160 107 98 83 33 756
G. H. Christie United Kingdom 15 422 1.0× 111 0.7× 155 1.4× 92 0.9× 58 0.7× 19 757
Leon S. Kind United States 15 238 0.6× 152 0.9× 84 0.8× 84 0.9× 98 1.2× 52 713
M. Landy United States 14 251 0.6× 162 1.0× 56 0.5× 47 0.5× 45 0.5× 30 588
J.G. Kreeftenberg Netherlands 18 300 0.7× 140 0.9× 152 1.4× 74 0.8× 162 2.0× 43 841
M Dörner Germany 11 229 0.6× 268 1.7× 128 1.2× 234 2.4× 74 0.9× 39 793
H. B. Levy United States 13 272 0.7× 345 2.2× 181 1.7× 148 1.5× 31 0.4× 21 928
W. H. Taliaferro United States 21 344 0.8× 261 1.6× 212 2.0× 258 2.6× 41 0.5× 44 1.1k
K Kato Japan 15 363 0.9× 121 0.8× 163 1.5× 27 0.3× 52 0.6× 28 691
Masaya Kawakami Japan 15 251 0.6× 291 1.8× 79 0.7× 88 0.9× 13 0.2× 51 716
Reet Tees Netherlands 13 470 1.1× 157 1.0× 91 0.9× 175 1.8× 24 0.3× 16 774

Countries citing papers authored by Phyllis D. Kind

Since Specialization
Citations

This map shows the geographic impact of Phyllis D. Kind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis D. Kind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis D. Kind more than expected).

Fields of papers citing papers by Phyllis D. Kind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis D. Kind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis D. Kind. The network helps show where Phyllis D. Kind may publish in the future.

Co-authorship network of co-authors of Phyllis D. Kind

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis D. Kind. A scholar is included among the top collaborators of Phyllis D. Kind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis D. Kind. Phyllis D. Kind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kind, Phyllis D., et al.. (1994). Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. Infection and Immunity. 62(7). 2754–2760. 19 indexed citations
2.
Kubicka-Muranyi, Malgorzata, et al.. (1990). Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation.. The Journal of Immunology. 145(7). 2132–2139. 76 indexed citations
3.
Kind, Phyllis D., et al.. (1988). Metallothionein induction in a human B cell line by stimulated immune cell products.. PubMed. 60(2). 211–24. 4 indexed citations
4.
Orenstein, Jan M., Olivia T. Preble, Phyllis D. Kind, & Richard S. Schulof. (1987). The Relationship of Serum Alpha-Interferon and Ultrastructural Markers in HIV-Seropositive Individuals. Ultrastructural Pathology. 11(5-6). 673–679. 25 indexed citations
5.
Schulof, R S, Marcelo B. Sztein, David M. Parenti, et al.. (1986). Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects.. PubMed. 5(5). 429–43. 6 indexed citations
6.
7.
Huang, Kun-Yen, Phyllis D. Kind, Elaine M. Jagoda, & Allan L. Goldstein. (1981). Thymosin Treatment Modulates Production of Interferon. Journal of Interferon Research. 1(3). 411–420. 44 indexed citations
8.
Ortaldo, John R., G D Bonnard, Phyllis D. Kind, & Ronald B. Herberman. (1979). Cytotoxicity by Cultured Human Lymphocytes: Characteristics of Effector Cells and Specificity of Cytotoxicity. The Journal of Immunology. 122(4). 1489–1494. 49 indexed citations
9.
Lucas, Stuart J., David W. Barry, & Phyllis D. Kind. (1978). Antibody production and protection against influenza virus in immunodeficient mice. Infection and Immunity. 20(1). 115–119. 19 indexed citations
10.
Simon, P L, John J. Farrar, & Phyllis D. Kind. (1977). The xenogeneic effect. III. Induction of cell-mediated cytotoxicity by alloantigen-stimulated thymocytes in the presence of xenogeneic reconstitution factor.. PubMed. 118(4). 1129–31. 10 indexed citations
11.
Cohen, John, et al.. (1975). Listeria Cell Wall Fraction: A B Cell Mitogen. The Journal of Immunology. 114(3). 1132–1134. 51 indexed citations
12.
Kind, Phyllis D., et al.. (1972). Enhancing Effect of Bacterial Endotoxins on Bone Marrow Cells in the Immune Response to SRBC. The Journal of Immunology. 108(5). 1453–1455. 64 indexed citations
13.
Campbell, P A & Phyllis D. Kind. (1971). Bone Marrow-Derived Cells as Target Cells for Polynucleotide Adjuvants. The Journal of Immunology. 107(5). 1419–1423. 25 indexed citations
14.
Campbell, Priscilla A. & Phyllis D. Kind. (1969). Differentiation of Antibody-Forming Cells. The Journal of Immunology. 102(4). 1084–1092. 2 indexed citations
15.
Kind, Phyllis D. & Priscilla A. Campbell. (1968). Differentiation of antibody-forming cells. I. Ratio of precursor cells to antibody-forming cells in the mouse spleen.. PubMed. 100(1). 55–60. 12 indexed citations
16.
Kind, Phyllis D. & Priscilla A. Campbell. (1968). Differentiation of Antibody-Forming Cells. The Journal of Immunology. 100(1). 55–60. 7 indexed citations
17.
Campbell, Priscilla A., David T. Rowlands, Michael Harrington, & Phyllis D. Kind. (1966). The Adjuvant Action of Endotoxin in Thymectomized Mice. The Journal of Immunology. 96(5). 849–853. 2 indexed citations
18.
Rowlands, David T., Henry N. Claman, & Phyllis D. Kind. (1965). THE EFFECT OF ENDOTOXIN ON THE THYMUS OF YOUNG MICE.. PubMed. 46. 165–76. 26 indexed citations
19.
20.
Kind, Phyllis D. & Arthur G. Johnson. (1959). Studies on the Adjuvant Action of Bacterial Endotoxins on Antibody Formation. The Journal of Immunology. 82(5). 415–427. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. H. Christie Breakdown of academic impact, for papers by Leon S. Kind Breakdown of academic impact, for papers by M. Landy Breakdown of academic impact, for papers by J.G. Kreeftenberg Breakdown of academic impact, for papers by M Dörner Breakdown of academic impact, for papers by H. B. Levy Breakdown of academic impact, for papers by W. H. Taliaferro Breakdown of academic impact, for papers by K Kato Breakdown of academic impact, for papers by Masaya Kawakami Breakdown of academic impact, for papers by Reet Tees
Rankless by CCL
2026